Thu. 22 Feb 2024, 4:32pm ET
Benzinga
Earnings, Earnings Beats, News
Collegium Pharmaceutical (NASDAQ:COLL) reported quarterly earnings of $1.58 per share which beat the analyst consensus estimate of $0.66 by 139.39 percent. The company reported quarterly sales of $149.75 million which beat the analyst consensus estimate of $147.82 million by 1.30 percent. This is a 15.53 percent increase over sales of $129.62 million the same period last year.